Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.

Wen J, Doerner J, Chalmers S, Stock A, Wang H, Gullinello M, Shlomchik MJ, Putterman C.

J Neuroinflammation. 2016 Apr 7;13(1):73. doi: 10.1186/s12974-016-0537-3.

2.

Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.

Wen J, Xia Y, Stock A, Michaelson JS, Burkly LC, Gulinello M, Putterman C.

J Autoimmun. 2013 Jun;43:44-54. doi: 10.1016/j.jaut.2013.03.002. Epub 2013 Apr 8.

3.

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Stock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C.

J Neuroinflammation. 2015 Nov 6;12:205. doi: 10.1186/s12974-015-0423-4.

4.

TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.

Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C.

J Autoimmun. 2015 Jun;60:40-50. doi: 10.1016/j.jaut.2015.03.005. Epub 2015 Apr 22.

5.

Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.

Chalmers SA, Wen J, Doerner J, Stock A, Cuda CM, Makinde HM, Perlman H, Bosanac T, Webb D, Nabozny G, Fine JS, Klein E, Ramanujam M, Putterman C.

Arthritis Res Ther. 2018 Jan 25;20(1):10. doi: 10.1186/s13075-017-1500-0.

6.

FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.

Shi D, Tian T, Yao S, Cao K, Zhu X, Zhang M, Wen S, Li L, Shi M, Zhou H.

Brain Behav Immun. 2018 May;70:293-304. doi: 10.1016/j.bbi.2018.03.009. Epub 2018 Mar 13.

PMID:
29548997
7.

AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.

White CA, Seth Hawkins J, Pone EJ, Yu ES, Al-Qahtani A, Mai T, Zan H, Casali P.

Autoimmunity. 2011 Dec;44(8):585-98. doi: 10.3109/08916934.2011.577128. Epub 2011 May 18. Erratum in: Autoimmunity. 2011 Dec;44(8):664.

8.

The central and multiple roles of B cells in lupus pathogenesis.

Chan OT, Madaio MP, Shlomchik MJ.

Immunol Rev. 1999 Jun;169:107-21. Review.

PMID:
10450512
9.

Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model.

Jeltsch-David H, Muller S.

Autoimmun Rev. 2014 Sep;13(9):963-73. doi: 10.1016/j.autrev.2014.08.015. Epub 2014 Aug 23. Review.

10.

B cell genotype determines the fine specificity of autoantibody in lpr mice.

Kakkanaiah VN, Sobel ES, MacDonald GC, Cheek RL, Cohen PL, Eisenberg RA.

J Immunol. 1997 Jul 15;159(2):1027-35.

PMID:
9218626
11.
12.

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.

Oaks Z, Winans T, Caza T, Fernandez D, Liu Y, Landas SK, Banki K, Perl A.

Arthritis Rheumatol. 2016 Nov;68(11):2728-2739. doi: 10.1002/art.39791.

13.

Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.

Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K.

Arthritis Rheum. 2011 Mar;63(3):738-48. doi: 10.1002/art.30183.

14.

Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.

Bökers S, Urbat A, Daniel C, Amann K, Smith KG, Espéli M, Nitschke L.

J Immunol. 2014 Apr 1;192(7):2994-3002. doi: 10.4049/jimmunol.1303367. Epub 2014 Mar 5.

15.

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.

Lenert P, Yasuda K, Busconi L, Nelson P, Fleenor C, Ratnabalasuriar RS, Nagy PL, Ashman RF, Rifkin IR, Marshak-Rothstein A.

Arthritis Res Ther. 2009;11(3):R79. doi: 10.1186/ar2710. Epub 2009 May 28.

16.

IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.

Rankin AL, Guay H, Herber D, Bertino SA, Duzanski TA, Carrier Y, Keegan S, Senices M, Stedman N, Ryan M, Bloom L, Medley Q, Collins M, Nickerson-Nutter C, Craft J, Young D, Dunussi-Joannopoulos K.

J Immunol. 2012 Feb 15;188(4):1656-67. doi: 10.4049/jimmunol.1003871. Epub 2012 Jan 9.

17.

Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.

Clark AG, Fan Q, Brady GF, Mackin KM, Coffman ED, Weston ML, Foster MH.

Autoimmunity. 2013 May;46(3):188-204. doi: 10.3109/08916934.2012.746671. Epub 2013 Jan 9.

18.

Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.

Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.

J Immunol. 2011 Sep 15;187(6):3413-21. doi: 10.4049/jimmunol.1101125. Epub 2011 Aug 17.

19.

Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.

Yasuda K, Watkins AA, Kochar GS, Wilson GE, Laskow B, Richez C, Bonegio RG, Rifkin IR.

PLoS One. 2014 Jul 30;9(7):e103478. doi: 10.1371/journal.pone.0103478. eCollection 2014.

20.

ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.

Odegard JM, DiPlacido LD, Greenwald L, Kashgarian M, Kono DH, Dong C, Flavell RA, Craft J.

J Immunol. 2009 Apr 1;182(7):4076-84. doi: 10.4049/jimmunol.0800758.

Supplemental Content

Support Center